Fosaprepitant Dimeglumine Injection
Fresenius Kabi USA, LLC
Open FDA's page for this record- Discontinued date
- 04/08/2026
- Update type
- New
- Initial posting date
- 04/08/2026
- Package NDC
- 63323-972-10
- Generic name
- Fosaprepitant Dimeglumine Injection
- Contact info
- 888-386-1300
- Related info
- Discontinuation of the manufacture of the drug
- Update date
- 04/08/2026
- Dosage form
- Injection
- Presentation
- Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)
- Company name
- Fresenius Kabi USA, LLC
- Status
- To Be Discontinued
- Therapeutic category
- Gastroenterology
- Harmonized identifiers (openFDA)
- Application number
- ANDA206197
- Brand name
- FOSAPREPITANT
- Generic name
- FOSAPREPITANT
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 63323-972
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- FOSAPREPITANT DIMEGLUMINE
- RxCUI
- 1731077
- SPL ID
- 864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c
- SPL set ID
- ffee61d1-c1c6-4224-871c-ab7ff6cd01e5
- Package NDC
- 63323-972-10
- UNII
- D35FM8T64X
